MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2013.04.010

Медицинская библиотека · The Annals of thoracic surgery · 2013

Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.

Atluri Pavan, Goldstone Andrew B, Kobrin Dale M, Cohen Jeffrey E, MacArthur John W, Howard Jessica L, Jessup Mariell L, Rame J Eduardo, Acker Michael A, Woo Y Joseph

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

There are an increasing number of elderly patients with end-stage heart failure. Destination mechanical circulatory support is often the only therapy available for these patients who are not transplant candidates. The outcomes after continuous flow left ventricular assist device (CF LVAD) implant in older patients remains unclear. We undertook this multi-institutional study to quantify short-term and midterm outcomes after CF LVAD implant in the elderly.

METHODS

We retrospectively analyzed all patients in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) national registry that underwent implant of a CF LVAD (June 2006 to April 2012). Patients were divided into 2 cohorts based upon age (<70 years [n = 4,439] and ≥ 70 years (n = 590]). Preoperative, intraoperative, and postoperative variables were analyzed. The primary endpoint, survival, was compared between cohorts.

RESULTS

Patients age 70 and older were more hemodynamically stable pre-VAD implant as evidenced by INTERMACS profile and inotrope dependence. Perioperative outcomes, including median bypass time (89 vs 89 minutes) and length of stay (0.657 vs 0.657 months) were similar between cohorts (p = not significant). Kaplan-Meier analysis revealed a significant difference in 2-year survival between patients aged 70 years or greater (63%) and less than 70 (71%, p < 0.001). Multivariable Cox proportional hazard analysis revealed age as an independent predictor of mortality during follow-up (p < 0.001). Nonetheless, midterm cumulative survival in the older cohort was still reasonable (63% at 2 years).

CONCLUSIONS

Multi-institutional analysis revealed advanced age as a predictor of increased mortality after CF LVAD implantation. Careful patient selection is critical in the elderly to optimize long-term outcomes after CF LVAD implantation.

Для цитирования: Atluri Pavan, Goldstone Andrew B, Kobrin Dale M, Cohen Jeffrey E, MacArthur John W, Howard Jessica L, Jessup Mariell L, Rame J Eduardo, Acker Michael A, Woo Y Joseph. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.. The Annals of thoracic surgery. 2013. DOI: 10.1016/j.athoracsur.2013.04.010.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.